# US 2015/0147395 A1 · Compounds and medical devices activated with solvophobic linkers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147395 A1
- Document ID: US20150147395A1
- Status: Published application
- Kind: A1
- Application number: 14/612,353
- Filed: 2015-02-03
- Published: 2015-05-28
- Earliest claimed: 2009-02-21
- Assignees: Sofradim Production
- Applicants: Sofradim Production
- Inventors: Sêbastien Ladet; Philippe Gravagna
- Web page: https://patentgrep.com/patent/US20150147395A1

## CPC

- A61K 47/549: {Sugars, nucleosides, nucleotides or nucleic acids}
- A61K 47/30: Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K 47/542: {Carboxylic acids, e.g. a fatty acid or an amino acid}
- A61K 47/61: the organic macromolecular compound being a polysaccharide or a derivative thereof
- A61K 47/62: the modifying agent being a protein, peptide or polyamino acid
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/48: with macromolecular fillers
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 31/14: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 2300/00: Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The present disclosure relates to compounds and medical devices activated with a solvophobic material functionalized with a first reactive member and methods of making such compounds and devices.

## Claims

### Claim at position 1

1-14. (canceled)

### Claim 15

A medical device comprising a solvent matrix and a compound including a solvophobic material and a solvophilic material, the solvophobic material being functionalized with a first reactive member, wherein the solvophilic material is positioned within the solvent matrix and the solvophobic material including the reactive member is positioned outside the solvent matrix.

### Claim 16 (depends on 15)

The medical device of claim 15, wherein the first reactive member is an electrophilic group.

### Claim 17 (depends on 15)

The medical device of claim 15, wherein the first reactive member is a nucleophilic group.

### Claim 18 (depends on 15)

The medical device of claim 15, wherein the first reactive member is an alkyne group.

### Claim 19 (depends on 15)

The medical device of claim 15, wherein the first reactive member is an azide group.

### Claim 20 (depends on 15)

The medical device of claim 15, wherein the solvent matrix is selected from the group consisting in a solid, a gel and a liquid.

### Claim 21 (depends on 15)

The medical device of claim 15, wherein the solvent matrix is hydrophilic.

### Claim 22 (depends on 21)

The medical device of claim 21, wherein the solvophilic material includes polyamides, hydrophilic polyurethanes, polylactones, polyimides, polylactams, poly-vinyl-pyrrolidone, polyvinyl alcohols, polyacrylic acid, polymethacrylic acid, poly(hydroxyethyl methacrylate), gelatin, dextran, oligosaccharides, chitosan, hyaluronic acid, alginate, chondroitin, mixtures and combinations thereof.

### Claim 23 (depends on 21)

The medical device of claim 21, wherein the solvophobic material includes polyethylene, polypropylene, hydrophobic polyurethanes, polyacrylates, polymethacrylates, fluoropolymers, polycaprolactone, polylactide, polyglycolide, phospholipids, and polyureas, poly(ethylene/-vinyl acetate), polyvinylchloride, polyesters, polyamides, polycarbonate, polystyrenes, polytetrafluoroethylene, silicones, siloxanes, fatty acids, and chitosan having high degrees of acetylation and mixtures and combinations thereof.

### Claim 24 (depends on 15)

The medical device of claim 15, further comprising a bioactive agent functionalized with a second reactive member, said bioactive agent being covalently bound to said solvophobic material by means of said first reactive member covalently bonding with said second reactive member.

### Claim 25 (depends on 18)

The medical device of claim 18, wherein the second reactive member is an azide group.

### Claim 26 (depends on 19)

The medical device of claim 19, wherein the second reactive member is an alkyne group.

### Claim 27 (depends on 19)

The medical device of claim 19, wherein the second reactive member is an alkene group.

### Claim 28 (depends on 24)

The medical device of claim 24, wherein the second reactive member is a nucleophilic group.

### Claim 29 (depends on 24)

The medical device of claim 24, wherein the second reactive member is an electrophilic group.
